CRNX:NASDAQ
Crinetics Pharmaceuticals
$84.95
0.00%
(0.00) 1D
Aug 31, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
CarePlus VietNam
·
1 month ago
Crinetics (CRNX) Q2 2026 Earnings: EPS Lands Above Forecast in Latest Trading; Closing Reaction: The Session Ends Near the Prior Level on the Day - Consensus Miss Rate
CarePlus VietNam
·
1 month ago
Crinetics Pharmaceuticals (CRNX) Holds Steady Near Key Support Amid Quiet Trading - WMA Signal
Profile
Crinetics Pharmaceuticals was a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.
In July 2026, Vertex Pharmaceuticals agreed to acquire the company for $10 billion. The acquisition closed in September of 2026. Wikipedia